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Abstract 
Introduction: Gambling Disorder (GD) is a prevalent psychiatric condition whose severity is 
typically defined by the number of DSM-5 criteria met out of a maximum of nine. The 
relationships between the levels of gambling severity, thus defined, and other measures of 
psychopathology and everyday functioning are clinically important.  
Methods: Baseline data were collected in patients with GD, conducted from 2001 to 2016. 
Participants completed clinical interviews and questionnaires. The impact of disease severity 
(mild, moderate, and severe) on clinical measures was characterized using analysis of variance 
models.  
Results: The sample included 574 adults with GD, of whom 73 [12.7%] had mild, 184 [32.1%] 
moderate, and 317 [55.2%] severe GD. The moderate and severe cases, compared to mild 
severity group tended be older, had later age of onset, lost more money to gambling in the 
preceding year, had worse quality of life, had higher state anxiety and depressive scores, 
consumed more nicotine via smoking per day, and had lower venturesomeness scores. The 
moderate and severe groups did not differ significantly on these measures, however. The Yale-
Brown Obsessive Compulsive Scale modified for Pathological Gambling (PG-YBOCS) 
discriminated significantly between all three groups.  
Conclusions: Several measures of psychopathology and functional impact of gambling 
symptoms appear similar between moderate and severe GD cases, while mild cases are clearly 
differentiated from moderate and severe cases. Thus, the current working definition of GD 
symptom severity boundaries has important limitations in terms of potential clinical utility.  
  
1.0 Introduction 
 Gambling is a commonplace activity across cultures, and for some individuals can 
develop into gambling disorder (GD), a psychiatric condition characterized by persistent, 
recurrent maladaptive patterns of gambling behavior. GD in turn is associated with impaired 
functioning, reduced quality of life, and high rates of bankruptcy, divorce, and incarceration [1-
2].  In the fifth edition of the Diagnostic and Statistical Manual (DSM-5), GD has been classified 
as a substance-related disorder [3].  As such, the DSM-5 has used the number of criteria met to 
define GD severity, mirroring the classification system used for substance use disorders.   
In the case of GD, many indicators are available to potentially operationalize clinical 
severity (e.g., money lost gambling as a percentage of earnings, impairment, or comorbidity) [4]. 
The committee responsible for GD in DSM-5 decided that a simple count of the criteria was 
sufficient to determine level of severity, given that this approach had been successfully applied 
to substance use disorder risk factors and consequences [5-7]. Thus, this simple criteria sum as 
an overall severity indicator was used for substance use disorders and then extension for GD: 
mild (four to five criteria), moderate (six to seven), and severe (eight or nine). Recent research, 
however, suggests that the individual criteria may not all be equivalent in terms of their 
contributions to the severity of the behavior [8].  For example, jeopardizing important matters, 
experiencing withdrawal, and needing financial assistance were all associated with a more severe 
level of GD than were chasing losses or being preoccupied with gambling (Sleczka et al., 2015). 
In a sample of gamblers recruited from the general population, endorsement of the item ‘social, 
financial, or occupational losses due to gambling’ was most indicative of more severe GD [9].  
The question remains as to whether simply summing the number of criteria endorsed by 
an individual accurately reflects GD symptom severity when each is weighted equally. The use 
of multiple measures of gambling severity across different samples has made it difficult to 
compare, and thereby understand, which may be most useful in understanding the severity of this 
complex disorder.  Therefore, we sought to examine the three levels of GD severity as 
determined by the DSM-5 against other clinical measures to determine if the DSM-5 categories 
of severity are clinically useful and comport with previous research on GD. This examination 
may provide a better understanding of thresholds of GD severity and how best to determine 
them.  As is the case with many psychiatric disorders, and because many gamblers can develop a 
significant problem without meeting all criteria, we hypothesized that the levels of GD severity 
set forth by the DSM-5 would not coincide with other measures of gambling severity commonly 
used clinically and in research settings.  
 
2.0 Materials and Methods 
2.1 Participants 
Participants included 574 adults with GD who had enrolled in various clinical, 
neuroimaging, and treatment research studies between 2001 and 2016. Data were collected prior 
to the initiation of any clinical procedures. A diagnosis of pathological gambling was confirmed 
by the primary investigator, a board-certified psychiatrist, using the criteria set forth by the 
DSM-IV [10] and the diagnoses were later confirmed to be consistent with the current 
requirements for GD using the DSM-5 [3]. Exclusion criteria for these studies included an 
inability to provide informed consent and inability to complete required assessment procedures. 
All study procedures were carried out in accordance with the Declaration of Helsinki. 
The Institutional Review Boards of the University of Minnesota and of the University of Chicago 
approved the procedures and accompanying consent forms. After study procedures were 
explained, all subjects provided informed written consent. 
After providing informed consent, participants completed a full psychiatric assessment, 
general demographic questionnaires, self-report and clinician-administered severity measures, as 
well as measures of impulsivity. Due to the inclusion of subjects from multiple studies, not all 
measures are available for each subject. 
 
2.2 Assessments 
Semi-structured interview was used to assess gambling behavior, including: age at onset 
of gambling, age at onset of gambling disorder, money lost to gambling, annual income, and 
problems due to gambling. In addition, the following measures were completed: 
Gambling symptoms during the past 12 months were evaluated using the Structured 
Clinical Interview for Gambling Disorder (SCI-GD), a nine-item instrument covering the DSM-5 
criteria for GD [10; modified to reflect DSM-5].  
Clinical Global Impressions-Severity (CGI): The CGI is a seven point scale used to 
denote the severity of a given disorder. Scores range from 1 (“Not ill at all”) to 7 (“Among the 
most severe cases”) according to an assessment from a trained clinician [11]. 
Yale-Brown Obsessive-Compulsive Scale modified for Pathological Gambling (PG-
YBOCS): The PG-YBOCS is a clinician-administered scale that assesses severity of urges and 
behaviors related to gambling during the past week, with higher scores indicating greater severity 
[12].  
Gambling Symptom Assessment Scale (GSAS): The GSAS is a reliable, self-report 
measure that assesses gambling symptom severity over the last week. Scores are based on ten 
questions scored from 0-4, with a maximum possible score of 40. The scale covers a range of 
symptoms related to GD, including the severity, duration, and frequency of both urges and 
behaviors related to gambling [13]. 
Hamilton Depression Rating Scale (HAM-D): The HAM-D is a clinician-administered 
scale which assesses a patient’s level of depression during the past month [14].  
Hamilton Anxiety Rating Scale (HAM-A): The HAM-A is a clinician-administered scale 
which assesses a patient’s level of anxiety during the past month [15]. 
Quality of Life Inventory (QoLI): The QoLI is a 16-item, self-report positive psychology 
scale that assesses areas of life such as health, love, work, recreation, home, friendships, self-
esteem, and standard of living [16].  
 The following paper-pencil measures of impulsivity were also examined, but only in a 
subset of the sample (added more recently to protocols): 
Barratt Impulsiveness Scale 11th version (BIS): The BIS is a 30 question self-report 
measure that is designed to assess various domains of impulsivity, including attentional 
impulsivity (AI), motor impulsivity (MI), and non-planning impulsivity (NI) [17]. 
Eysenck Impulsivity Questionnaire (EIQ): The EIQ is a 54 question self-report measure 
comprised of three subscales: impulsivity, venturesomeness, and empathy [18].  Impulsivity in 
the EIQ can be characterized as behaving without thinking and without realizing the risk 
involved in the behavior, whereas venturesomeness is being conscious of the risk of the behavior 
but acting anyway. 
 
Data Analysis 
Based on the nine criteria for GD in the DSM-5, subjects were categorized as mild (score 
4-5), moderate (score of 6-7), or severe GD symptoms (score of 8-9) [3]. Group differences on 
demographic, clinical, and personality measures were explored using analysis of variance 
(ANOVA) for continuous variables and chi-square tests for categorical variables. Post hoc paired 
comparisons were undertaken when the initial omnibus tests were statistically significant. No 
imputation was made for missing data.  This being an exploratory study, statistical significance 
was defined as p<0.05 uncorrected. SPSS Statistics version 18 (SPSS Inc., 2009) was used for all 
analyses. 
 
3.0 Results 
574 adults with GD (mean age 44.4 [±13.3] years) were evaluated, of whom 310 (54%) 
were male. The mean score on the PG-YBOCS for the entire sample was 22.8 (±5.9), and the 
mean G-SAS score was 35.7 (±10.8), both of which are in keeping with average disease severity 
being moderate in GD. On average, subjects lost a mean of $18,337 (±22,318) US dollars to 
gambling in the preceding year. Seventy-three [12.7%] patients had mild severity, 184 [32.1%] 
had moderate severity, and 317 [55.2%] had severe GD.  
 In terms of demographic variables, those with fewer DSM-5 criteria (mild severity) were 
significantly younger than both other groups. The mild severity group had a significantly higher 
proportion of males when compared to the severe group. The groups did not differ in terms of 
levels of education.  
 For the clinical variables, both the moderate and severe groups exhibited significantly 
older age of GD onset (but not age at first gamble), higher loss of money to gambling in the past 
year, lower quality of life, higher state anxiety plus depression scores, and more nicotine 
consumption (smoking) relative to the mild group. Moderate and severe groups did not differ 
significantly from each other on these measures. The PG-YBOCS total scores differed 
significantly between all three groups, whereas the G-SAS and CGI-S measures were 
significantly higher in the severe group versus both other groups, while mild and moderate 
groups did not differ significantly from each other on these measures. Weekly gambling 
frequency was insensitive to group differences. No significant group differences were found for 
presence of categorical mood, anxiety, and substance use disorders or in terms of the mean 
number of co-occurring disorders across groups. 
On the personality questionnaires, which were available for only a subsection of the total 
pooled cohort (see Table for N) the moderate and high severity groups had significantly lower 
Eysenck venturesomeness scores than the mild group. The moderate and high severity groups did 
not differ from each other on this measure. No other significant group differences were 
identified.  
 
4.0 Discussion  
In this large study of adults with GD we found that key measures of psychopathology and 
functional impact of gambling symptoms appear similar between moderate and severe GD cases, 
whereas mild cases are more clearly differentiated from moderate and severe cases. In addition, 
not all gambling severity scales differed between the mild and moderate severity groups. This is 
the first study we are aware of that has examined the clinical utility of the severity measure 
recently published for GD in the DSM-5, and this study suggests that the current working 
definition of GD symptom severity boundaries has important limitations. This finding therefore 
may have important implications for both treatment and research. 
In terms of treatment of GD, clinicians may find that improvement from severe GD to 
moderate GD in terms of number of criteria has little, if any, relationship to change in severity of 
gambling behavior or functional outcomes. Additionally, if the intensity of GD treatment 
approaches is stratified based on these severity categories, applying treatment differently 
between moderate and severe GD clients may be a sub-optimal allocation of treatment resources. 
For research, these findings may have notable implications for scale selection, participant 
inclusion criteria, and definitions of treatment response. The PG-YBOCS, unlike the GSAS and 
CGI-Improvement scales, was able to significantly discriminate mild from moderate groups. 
Thus, this scale may be preferable as a primary outcome measure in clinical trials (as these two 
groups appear clinically meaningful).  Insensitivities within the GSAS and CGI do not appear to 
be due to limited statistical power in this study, as the PG-YBOCS was able to discriminate all 
three groups with high significance. When considering participant selection for future research, 
these data suggest that the PG-YBOCS woould be the preferred outcome measure for treatment 
trials if severe gamblers are included.  As this category of gamblers did not differ from moderate 
gamblers on most other measures assessed in this analysis,  any improvement they demonstrate 
could go undetected  (i.e. they might decrease their symptom severity from severe  to a moderate 
level)on many outcome measures. This in turn may inform how treatment response is defined, as 
movement from severe to moderate GD may not be associated with other measures of 
improvement. 
 It was potentially interesting that on trait measures, only the venturesomeness subscale of 
the Eysenck was significantly different between groups based on GD severity.  Higher 
venturesomeness in the mild group might suggest that people prone to habit or less exploratory 
behavior might be more prone towards getting 'stuck' and more severe disease. 
This study has several limitations. First, because both clinical and non-treatment-seeking 
samples were included, it is unclear how generalizable our results are to individuals with GD in 
the community. Second, this research used a cross-sectional analysis and, therefore, causal 
relationships cannot be confirmed; the analysis does, however, provide reliable measures of 
association. Third, we did not examine the equivalency of different criteria in terms of functional 
or severity impact in this study as this is a distinct topic from assessing the impact of current 
thresholds using total criteria met. Having said that, future work may wish to explore the role of 
different criteria using approaches such as latent class analysis. Despite these limitations, the 
study sample was relatively large for the majority of measures (personality measures were only 
collected for a relatively small sub-set of participants), the inclusion/exclusion criteria were 
relatively broad, and the study used both self-report and interviewer-administered measures with 
established psychometric properties.  
 In conclusion, these results suggest that measuring severity of GD using the number of 
diagnostic criteria, per the DSM-5 guidelines, may have limited clinical and research utility. In 
addition, it appears that the differences between moderate and severe gamblers based on the 
DSM-5 are not consistently associated with other measures of disease severity. Clinicians and 
researchers may therefore want to use alternative measures of GD severity (such as the PG-
YBOCS) that allow for more accurate differentiation of groups based on gambling severity.   
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Table 1. Demographic Variables of Subjects with Gambling Disorder Based on DSM-5 
Level of Severity 
Variables Mild 
(4-5 criteria) 
N=73 
Moderate  
(6-7 criteria) 
N=184 
Severe   
(8-9 criteria) 
N=317 
Omnibus 
p value # 
 
Mild vs. 
Moderate 
Moderate 
vs. Severe 
Mild vs. 
Severe 
Age  38.7 (17.2) 45.4 (13.5) 45.1 (11.7) <0.001 *** n.s. *** 
Gender, N 
Male 
48 [65.7%] 106 [57.6%] 156 [49.2%] 0.019 n.s. n.s. * 
Education 
Level 
1.8 (0.5) 1.7 (0.6) 1.6 (0.5) 0.053 --- --- --- 
# Omnibus test is ANOVA for continuous variables and chi-square for categorical variables. * 
p<0.05, ** p<0.01, *** p<0.001, significant paired difference by post hoc test. All values are 
Mean (Standard Deviation) unless otherwise noted. 
DSM-5 = Diagnostic and Statistical Manual, Fifth Edition   
Table 2. Clinical Variables of Subjects with Gambling Disorder Based on DSM-5 Level of 
Severity 
Variables Mild 
(4-5 criteria) 
N=73 
Moderate  
(6-7 criteria) 
N=184 
Severe   
(8-9 criteria) 
N=317 
Omnibus 
p value # 
 
Mild vs. 
Moderate 
Moderate 
vs. Severe 
Mild vs. 
Severe 
Age at onset of 
gambling  
24.0 (14.7) 26.4 (13.2) 24.4 (12.2) 0.211 --- --- --- 
Gambling 
disorder age at 
onset 
31.4 (15.4) 36.7 (14.0) 34.5 (12.8) 0.020 ** n.s. n.s. 
$ Lost (Past 
Year) 
8525 (13154) 17419 
(19400) 
22984 
(25676) 
<0.001 * n.s. *** 
G-SAS, Total 
Score 
32.6 (11.3) 34.4 (10.1) 36.7 (11.0) 0.026 n.s. * * 
PG-YBOCS 
- Urge 
- Behavior 
- Total 
 
7.5 (3.5) 
8.6 (3.8) 
16.1 (6.8) 
 
10.7 (3.2) 
11.5 (3.3) 
22.2 (5.3) 
 
12.2 (2.7) 
12.7 (2.9) 
24.9 (5.0) 
 
<0.001 
<0.001 
<0.001 
 
*** 
*** 
*** 
 
*** 
** 
*** 
 
*** 
*** 
*** 
Gambling 
Frequency 
4.1 (2.8) 4.7 (3.0) 5.0 (2.5) n.s. --- --- --- 
CGI-S 4.3 (0.5) 4.5 (0.7) 5.0 (0.8) <0.001 n.s. *** *** 
QoLI 44.2 (13.4) 35.0 (16.7) 31.4 (15.1) <0.001 ** n.s. *** 
HAMA 6.0 (6.0) 8.0 (5.4) 8.9 (5.1) 0.009 * n.s. ** 
HAMD 5.5 (4.8) 8.5 (5.7) 8.9 (4.9) <0.001 ** n.s. *** 
Psychiatric 
Comorbidity 
 -Mood 
 -Anxiety 
 -Substance Use  
 
 
7 [18.9%] 
2 [5.4%] 
18 [25.0%] 
 
 
13 [35.6%] 
11 [7.7%] 
36 [19.6%] 
 
 
23 [8.1%] 
18 [6.3%] 
57 [18.0%] 
 
 
0.103 
0.805 
0.395 
 
 
--- 
--- 
--- 
 
 
--- 
--- 
--- 
 
 
--- 
--- 
--- 
Nicotine use 
(packs per day) 
0.3 (0.5) 0.5 (0.5) 0.6 (0.5) <0.001 ** n.s. *** 
# Omnibus test is ANOVA for continuous variables and chi-square for categorical variables. * 
p<0.05, ** p<0.01, *** p<0.001, significant paired difference by post hoc test. 
CGI-S = Clinical Global Impression–Severity; DSM-5 = Diagnostic and Statistical Manual, Fifth 
Edition; GSAS = Gambling Symptom Assessment Scale; HAMA = Hamilton Anxiety Rating 
Scale; HAMD = Hamilton Depression Rating Scale; PG-YBOCS = Yale-Brown Obsessive-
Compulsive Scale modified for Pathological Gambling; QoLI = Quality of Life Inventory; 
All values are mean (standard deviation) or N (%) unless otherwise noted. 
 Table 3. Personality Variables of Subjects with Gambling Disorder Based on DSM-5 Level 
of Severity 
Variables Mild 
(4-5 criteria) 
N=36 
Moderate  
(6-7 criteria) 
N=42 
Severe   
(8-9 criteria) 
N=31 
Omnibus 
p value # 
 
Mild vs. 
Moderate 
Moderate 
vs. Severe 
Mild vs. 
Severe 
Eysenck 
Impulsivity Scale 
- Impulsiveness 
- Venturesomeness 
- Empathy 
 
 
11.1 (3.4) 
10.8 (2.9) 
13.2 (3.6) 
 
 
10.5 (4.3) 
8.7 (3.4) 
11.9 (3.7) 
 
 
11.7 (4.6) 
8.6 (4.0) 
13.4 (3.4) 
 
 
0.480 
0.010 
0.139 
 
 
--- 
** 
--- 
 
- 
-- 
n.s. 
--- 
 
 
--- 
** 
--- 
Barratt 
Impulsiveness 
Scale 
- Attentional 
- Motor 
- Non-planning 
 
 
 
17.4 (5.3) 
26.3 (4.5) 
26.4 (5.4) 
 
 
 
18.0 (4.1) 
26.4 (5.2) 
27.5 (5.4) 
 
 
 
18.8 (4.3) 
27.2 (5.4) 
29.2 (5.7) 
 
 
 
0.524 
0.748 
0.135 
 
 
 
--- 
--- 
--- 
 
 
 
--- 
--- 
--- 
 
 
 
--- 
--- 
--- 
# Omnibus test is ANOVA. * p<0.05, ** p<0.01, *** p<0.001, significant paired difference by 
post hoc test. All values are mean (standard deviation) unless otherwise noted. DSM-5 = 
Diagnostic and Statistical Manual, Fifth Edition 
 
 
 
 
 
 
 
 
 
